AEs (safety population [N = 100])
| AE . | Any grade . | Grade ≥3 . |
|---|---|---|
| All AEs | 100 (100) | 74 (74) |
| Asthenia | 51 (51) | 2 (2) |
| Neutropenia* | 48 (48) | 47 (47) |
| Constipation | 42 (42) | 0 (0) |
| Cough | 36 (36) | 2 (2) |
| Diarrhea | 35 (35) | 2 (2) |
| Infusion-related reaction | 28 (28) | 3 (3) |
| Bronchitis | 27 (27) | 0 (0) |
| Decreased weight | 26 (26) | 1 (1) |
| Arthralgia | 25 (25) | 0 (0) |
| Rash | 25 (25) | 2 (2) |
| Rhinitis | 21 (21) | 0 (0) |
| Nausea | 18 (18) | 1 (1) |
| Nasopharyngitis | 17 (17) | 0 (0) |
| Back pain | 15 (15) | 0 (0) |
| Pruritus | 15 (15) | 1 (1) |
| Urinary tract infection | 15 (15) | 0 (0) |
| Peripheral edema | 13 (13) | 1 (1) |
| Muscle spasms | 12 (12) | 1 (1) |
| Upper abdominal pain | 11 (11) | 0 (0) |
| Erythema | 11 (11) | 0 (0) |
| Peripheral neuropathy† | 11 (11) | 1 (1) |
| Sinusitis | 11 (11) | 0 (0) |
| AE . | Any grade . | Grade ≥3 . |
|---|---|---|
| All AEs | 100 (100) | 74 (74) |
| Asthenia | 51 (51) | 2 (2) |
| Neutropenia* | 48 (48) | 47 (47) |
| Constipation | 42 (42) | 0 (0) |
| Cough | 36 (36) | 2 (2) |
| Diarrhea | 35 (35) | 2 (2) |
| Infusion-related reaction | 28 (28) | 3 (3) |
| Bronchitis | 27 (27) | 0 (0) |
| Decreased weight | 26 (26) | 1 (1) |
| Arthralgia | 25 (25) | 0 (0) |
| Rash | 25 (25) | 2 (2) |
| Rhinitis | 21 (21) | 0 (0) |
| Nausea | 18 (18) | 1 (1) |
| Nasopharyngitis | 17 (17) | 0 (0) |
| Back pain | 15 (15) | 0 (0) |
| Pruritus | 15 (15) | 1 (1) |
| Urinary tract infection | 15 (15) | 0 (0) |
| Peripheral edema | 13 (13) | 1 (1) |
| Muscle spasms | 12 (12) | 1 (1) |
| Upper abdominal pain | 11 (11) | 0 (0) |
| Erythema | 11 (11) | 0 (0) |
| Peripheral neuropathy† | 11 (11) | 1 (1) |
| Sinusitis | 11 (11) | 0 (0) |